Effective Dec. 7, 2022, Medicaid and NC Health Choice cover bendamustine hydrochloride injection, for intravenous use (Vivimusta).
Topics Related to Bulletins
Effective Jan. 9, 2023, Medicaid and NC Health Choice cover mosunetuzumab-axgb injection, for intravenous use (Lunsumio).
Optum has been awarded a contract to implement the solution, scheduled to launch in 2024.
NC Medicaid reimburses qualified providers for medically necessary circumcision for newborns and non-newborns.
Summary of updates to Clinical Coverage Policy 5A-3 with an effective date of Feb. 1, 2023.
Effective March 1, 2023, through June 30, 2023, NC Medicaid is implementing a temporary rate increase of 40%.
This companion guide is designed to create uniformity in the completion of the Patient Risk List.
On March 1, 2023, Beacon Health Options is changing their name to Carelon Behavioral Health.
Effective Feb. 1, 2022, NC Medicaid increased the Intermediate Care Facilities for Individuals with Intellectual Disabilities provider assessment.
Implementation is delayed until Oct. 1, 2023.